Cormorant Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-250,000	Closed	-$9.48M	–	62
2024 Q1	$9.48M	Sell	250,000 -687,080	-73%	-$26.1M	0.42%	45
2023 Q4	$20.2M	Buy	+937,080	New	+$20.2M	0.96%	29